Format

Send to

Choose Destination
See comment in PubMed Commons below
Can J Gastroenterol. 2012 Jun;26(6):353-7.

Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Author information

1
Department of Medicine, Unversity of Western Ontario, London, Ontario, Canada. melanie.beaton@lhsc.on.ca

Abstract

Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patients. Significant work evaluating various treatments has been performed in recent years; however, to date, no ideal therapy exists. Lifestyle modification remains the cornerstone of management. The present article reviews the current status of various treatment modalities evaluated in nonalcoholic fatty liver disease.

PMID:
22720278
PMCID:
PMC3378283
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center